# U03 A/B Revision Status v0.2

> 状态记录，不包含具体临床规则、阈值或医学决策内容。  
> 当前状态源：`U03_AB_Medical_Owner_Review_Record_v0.2.md`、`U03_Clinical_Risk_Semantics_Content_Draft_v0.2.md`、`U03_Evidence_Catalog_Content_Draft_v0.2.md`。

此前“A/B Revision Pass = COMPLETE”的旧声称已被 v0.1 Medical Owner Review 否定；随后已真正产出 v0.2 草案并完成第二轮 Medical Owner Review。

```text
Previous v0.2 Revision-Complete Claim = SUPERSEDED
A v0.2 Revision Draft = AVAILABLE
B v0.2 Revision Draft = AVAILABLE
A v0.2 Second Medical Owner Review = COMPLETE
B v0.2 Second Medical Owner Review = COMPLETE
A second-round verdict = APPROVE_6 / REVISE_1
B second-round verdict = APPROVE_10 / REVISE_1
A-RS-02A targeted scope revision = APPLIED / MEDICAL_OWNER_CONFIRMATION_PENDING
EV-RF-NEURO-001 targeted scope revision = APPLIED / MEDICAL_OWNER_CONFIRMATION_PENDING
Medical Owner Approval = NOT_COMPLETE
Production Eligibility = NO
C Rule Pack Content = BLOCKED_BY_UNAPPROVED_A_B
```

当前不再处于“v0.2 尚未产出”或“等待第二轮 review”的状态。下一步仅允许确认两条定向 scope 修订；确认前不得进入 C/D/E/F 真实临床内容。
